| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.41 | 0.02 |